Colorectal cancer (CRC) is the third leading cause of cancer death in men and women in the United States.
1 Although non-Hispanic whites have experienced declines in CRC incidence and mortality, other racial/ethnic minority groups have not experienced similar declines.
2 Colorectal cancer screening is effective at reducing CRC mortality, and expert groups, including the US Preventive Services Task Force (USPSTF) recommend CRC screening with several testing options.
3-5 The US National Colorectal Cancer Roundtable, a coalition of public, private, and volunteer organizations, has set a goal of increasing US screening rates to 80% by 2018, an ambitious target that would have a substantial public health impact.
6,7 Unfortunately, screening remains underused, especially among vulnerable populations, including those with Medicaid, no health insurance, low educational attainment, limited English proficiency, and members of racial/ethnic minority groups.
8-14 Screening rates among Latinos, the largest racial/ethnic minority group in the United States, are substantially lower than in the general population.
9,13,15,16 To increase CRC screening nationally, interventions that address multiple patient- and system-level screening barriers are needed, particularly in care settings where diverse, vulnerable populations are served.